Early research (Phase 1)Study completedNCT00398307What this trial is testingEvaluating Patients With Varying Degrees of Renal FunctionWho this might be right forRenal Impairment Taiho Oncology, Inc. 24
Early research (Phase 1)Study completedNCT03284164What this trial is testingEvaluation of Effect of Renal Impairment on the PK of Tenofovir ExalidexWho this might be right forRenal Impairment ContraVir Pharmaceuticals, Inc. 16
Early research (Phase 1)Study completedNCT05927415What this trial is testingTest How Kidney Problems Influence the Blood Concentrations of EfgartigimodWho this might be right forRenal Impairment argenx 33
Post-approval studies (Phase 4)Ended earlyNCT00793182What this trial is testingEffects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed TomographyWho this might be right forRenal Impairment Guerbet 6
Post-approval studies (Phase 4)Study completedNCT01035320What this trial is testingPlatelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering TreatmentWho this might be right forDiabetes MellitusImpaired Renal Function Karolinska Institutet 39
Early research (Phase 1)Study completedNCT02508506What this trial is testingPharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal FunctionWho this might be right forRenal Impairment Alkermes, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT02058095What this trial is testingStudy to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)Who this might be right forCardiomyopathyRenal Impairment Mayo Clinic 22
Early research (Phase 1)Study completedNCT02301117What this trial is testingA Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal ImpairmentWho this might be right forAdvanced Solid Tumors Taiho Oncology, Inc. 43
Early research (Phase 1)Study completedNCT01875523What this trial is testingPK of Serelaxin in Severe Renal Impairment and ESRDWho this might be right forRenal Failure, ChronicEnd-Stage Renal Disease Novartis Pharmaceuticals 36
Early research (Phase 1)Study completedNCT02894385What this trial is testingEffect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)Who this might be right forPharmacokineticsHepatic InsufficiencyRenal Insufficiency Bayer 29
Early research (Phase 1)Looking for participantsNCT06708520What this trial is testingPharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control ParticipantsWho this might be right forRenal Impairment Noucor Health S.A. 48
Early research (Phase 1)Study completedNCT02007941What this trial is testingComparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function SubjectsWho this might be right forRenal ImpairmentHealthy Chong Kun Dang Pharmaceutical 28
Early research (Phase 1)Study completedNCT02286622What this trial is testingA Single Dose Evaluation of the Effects of Renal Impairment on Deflazacort PharmacokineticsWho this might be right forRenal Impairment PTC Therapeutics 16
Early research (Phase 1)Study completedNCT01737866What this trial is testingPharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal InsufficiencyWho this might be right forHeart Failure Cytokinetics 13
Testing effectiveness (Phase 2)WithdrawnNCT02397395What this trial is testingAn Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.Who this might be right forRenal ImpairmentEnd-stage Renal Disease Janssen R&D Ireland
Early research (Phase 1)Ended earlyNCT00879645What this trial is testingPharmacokinetic Assessment of Sodium Sulfide in Subjects With Impaired Renal FunctionWho this might be right forRenal Impairment Mallinckrodt 28
Post-approval studies (Phase 4)Study completedNCT00717067What this trial is testingPharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal FunctionWho this might be right forHuman Immunodeficiency Virus (HIV) Infection ViiV Healthcare 30
Early research (Phase 1)Ended earlyNCT01675973What this trial is testingAssess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of RanolazineWho this might be right forSevere Renal Impairment Gilead Sciences 4
Not applicableStudy completedNCT02246101What this trial is testingWorld Trade Center (WTC) RENALWho this might be right forCardiac DiseaseCardiopulmonary DiseaseRenal Disease+1 more Icahn School of Medicine at Mount Sinai 406
Not applicableUnknownNCT03767803What this trial is testingCollection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant WomenWho this might be right forPre-EclampsiaHypertensionProteinuria in Pregnancy+6 more Progenity, Inc. 344